The Lancet Haematology/X
Sep 2, 2025, 13:53
Cost-Effective Strategies to Reduce Anaemia Highlighted in The Lancet Haematology
The Lancet Haematology shared a post on X:
”September issue. Cost-effective targets to reduce anaemia, costs of anaemia interventions, ferritin-guided iron supplementation for donors, oral decitabine or cedazuridine for AML and MDS. Cover: Commission on global anaemia reduction targets.”
Read more here.
Find more on Hemostasis Today.
-
Jan 31, 2026, 08:13Ming Y Lim On The Value of National Mentorship
-
Jan 31, 2026, 06:37Christian Schulze Presents The Post-Hoc Analysis of the DanGer Shock Trial
-
Jan 31, 2026, 06:27Negative Trials Matter: Anne Hege Aamodt Shares The TenCRAOS Trial
-
Jan 31, 2026, 06:18Manuel Requena: Cherrypicking Inclusion in Clinical Trials May Underestimate The Effect of An Intervention
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets